The National Monitoring Centre for Drugs (NMCD), which is a specialist in the Ministry of Health of the Slovak Republic, successfully passed the evaluation of the European Drug Agency (EUDA). Level reached It has been awarded the status of the EUDA assigned.
The evaluation of the EUDA is a technical assessment of the Reitox national contact points. The evaluation shall include an assessment of the ability of the national contact point to ensure reliable, reliable and accurate collection and provision of information on the drug situation according to European requirements.
I am pleased that Slovakia has a result in the monitoring of the drug situation, which has been proven in an independent European evaluation. This is an important part of our ability to monitor the development of the drug situation and to respond to new public health challengessaid Minister of Health Kamil Šaško.
The National Monitoring Centre for Drugs provides the collection and professional processing of data on the drug situation in Slovakia. It evaluates and provides data to the European Drugs Agency. At the same time, expert outputs are used to monitor trends in the drug situation and for drug policy-making.
The outcome of the evaluation confirms the position of the Slovak National Contact Point as an expert partner of EUDA in providing information on drug issues. Certification shall be valid for five years under the agreed procedure until institutional change occurs.